Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Sebastian Giebel, David I. Marks, Nicolas Boissel, Frederic Baron, Sabina Chiaretti, Fabio Ciceri, Jan J. Cornelissen, Michael Doubek, Jordi Esteve, Adele Fielding, Robin Foa, Norbert Claude Gorin, Nicola Gökbuget, Helene Hallböök, Dieter Hoelzer, Elena Paravichnikova, Josep Maria Ribera, Bipin Savani, Anita W. Rijneveld, Christoph SchmidUlla Wartiovaara-Kautto, Mohamad Mohty, Arnon Nagler, Hervé Dombret

Research output: Contribution to journalReview articlepeer-review

Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) in first complete remission is a standard of care for adult patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) and high risk of relapse. However, the stratification systems vary among study groups. Inadequate response at the level of minimal residual disease is the most commonly accepted factor indicating the need for alloHSCT. In this consensus paper on behalf of the European Working Group for Adult Acute Lymphoblastic Leukemia and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, we summarize available evidence and reflect current clinical practice in major European study groups regarding both indications for HSCT and particular aspects of the procedure including the choice of donor, source of stem cells and conditioning. Finally, we propose recommendations for daily clinical practice as well as for planning of prospective trials.

Original languageEnglish
Pages (from-to)798-809
Number of pages12
JournalBone Marrow Transplantation
Volume54
Issue number6
DOIs
StatePublished - 1 Jun 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)'. Together they form a unique fingerprint.

Cite this